September 27, 2016 11:31 AM ET

Biotechnology

Company Overview of Fenway Pharmaceuticals, Inc.

Key Executives for Fenway Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Mark B. Skaletsky 99 RelationshipsChairman of the Board, Chief Executive Officer and President68

Fenway Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Mark B. Skaletsky 99 RelationshipsFenway Pharmaceuticals, Inc.68
View All Board Members

Fenway Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
383.7K
Bonus
264.0K
Total Short Term Compensation
479.1K
Total Value of Options
33.3M
Compensation as of Fiscal Year
Fenway Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Navidea Biopharmaceuticals, Inc Announces Executive Changes
September 26, 2016 9:00 PM ET
Prothena Corporation plc Announces Dale B. Schenk, President and Chief Executive Officer, Is Taking A Medical Leave of Absence
September 26, 2016 8:12 PM ET
Syros Pharmaceuticals Appoints Gerald E. Quirk as Chief Legal Officer
September 26, 2016 12:05 PM ET
Intrexon Corporation Appoints Thomas P. Bostick as Head of Environment Sector
September 26, 2016 12:00 PM ET
Swedish Orphan Biovitrum AB Announces Appointment of Milan Zdravkovic as Senior Vice President, Head of Research & Development
September 26, 2016 10:04 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Fenway Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.